EGFR and prostate carcinoma: In support of this notion, a recent study highlighted a mechanism by which the interaction of UGT2B28 with the adaptor huntingtin interacting protein 1 triggered epidermal growth factor receptor signaling to promote prostate cancer cell proliferation and invasion [24].